Literature DB >> 28697499

Perinatal Outcomes of Non-Primary Maternal Cytomegalovirus Infection: A 15-Year Experience.

Giuliana Simonazzi1, Alessandra Curti, Francesca Cervi, Liliana Gabrielli, Margherita Contoli, Maria Grazia Capretti, Nicola Rizzo, Brunella Guerra, Antonio Farina, Tiziana Lazzarotto.   

Abstract

OBJECTIVE: To evaluate perinatal outcomes in case of non-primary maternal cytomegalovirus (CMV) infection.
METHODS: We performed a retrospective cohort study of pregnant women with active CMV infection referred to our unit over a 15-year period (January 2000 to December 2014). Non-primary infection was diagnosed on the basis of the results of confirmatory serological and virological tests (avidity test, immunoblotting, real-time PCR-DNA). The vertical transmission rate and the percentage of symptomatic congenital infection were determined in this group of patients.
RESULTS: A total of 205 pregnant women were enrolled. Congenital infection occurred in 7 (3.4%) fetuses/neonates. Symptomatic disease was present at birth in 3 of the 7 congenitally infected neonates (1.5%). Two out of 3 symptomatic newborns presented a pathologic second-trimester ultrasound scan.
CONCLUSION: Maternal immunity offers substantial protection against intrauterine transmission of CMV infection, but not against disease once the fetus is infected.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Congenital cytomegalovirus infection; Non-primary infection; Ultrasound scan

Mesh:

Year:  2017        PMID: 28697499     DOI: 10.1159/000477168

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  13 in total

1.  Preventing Infection by Human Cytomegalovirus.

Authors:  Stanley A Plotkin
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

Review 2.  Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.

Authors:  Hunter K Roark; Jennifer A Jenks; Sallie R Permar; Mark R Schleiss
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

Review 3.  Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection.

Authors:  Mark R Schleiss; Sallie R Permar; Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

4.  The Impact of IgG transplacental transfer on early life immunity.

Authors:  Genevieve G Fouda; David R Martinez; Geeta K Swamy; Sallie R Permar
Journal:  Immunohorizons       Date:  2018-01-01

Review 5.  Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.

Authors:  Sallie R Permar; Mark R Schleiss; Stanley A Plotkin
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 6.  Human Cytomegalovirus Congenital (cCMV) Infection Following Primary and Nonprimary Maternal Infection: Perspectives of Prevention through Vaccine Development.

Authors:  Giuseppe Gerna; Daniele Lilleri
Journal:  Vaccines (Basel)       Date:  2020-04-23

Review 7.  Vaccination against the human cytomegalovirus.

Authors:  Stanley A Plotkin; Suresh B Boppana
Journal:  Vaccine       Date:  2018-04-03       Impact factor: 3.641

Review 8.  Development of novel vaccines against human cytomegalovirus.

Authors:  Xinle Cui; Clifford M Snapper
Journal:  Hum Vaccin Immunother       Date:  2019-04-24       Impact factor: 3.452

9.  Maternal cytomegalovirus immune status and hearing loss outcomes in congenital cytomegalovirus-infected offspring.

Authors:  Gail J Demmler-Harrison; Jerry A Miller
Journal:  PLoS One       Date:  2020-10-09       Impact factor: 3.240

Review 10.  Maternal Immunity and the Natural History of Congenital Human Cytomegalovirus Infection.

Authors:  William J Britt
Journal:  Viruses       Date:  2018-08-03       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.